retatrutide drug trial FDA Approval Status 2026: Everything We Know So Far New GLP-1 obesity drug, retatrutide,

Mayim Bialik is recalling a nightmarish experience trying a GLP-1 drug for her health

Retatrutide, an innovative agent, represents a potential advancement in therapy

Discussing Pfizer's savvy acquisition of Metsera and critiquing the GLP-1 'gap analysis' many outsiders promote as a reason all the Big Pharmas will be in GLP-1

Although glucagon-like peptide-1 receptor agonist use may increase the risk for retained gastric contents in those undergoing endoscopic procedures, a 24-hour clear liquid diet may be “protective&rdquo

Does insurance cover Wegovy, Zepbound, semaglutide, or tirzepatide for weight loss in California

Despite their established glucose-lowering effects, there is no consensus among global experts and modern guidelines regarding the priority of SUs in relation to other therapeutic options, given the lack of evidence that SUs are associated with a low risk of macrovascular events and excess mortality